Gene Therapy for Rare Disorders 2018 will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Incorporating insights from Spark, Bluebird Bio, Pfizer and GSK, this unique conference will delve into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.
Back to All Events
Earlier Event: April 27Annual Conference of the British Society for Gene & Cell Therapy (BSGCT)
Later Event: May 2International Society for Cellular Therapy (ISCT) Annual Meeting